Chapter 11 : Microbial Interference with Host Inflammatory Responses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Microbial Interference with Host Inflammatory Responses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817848/9781555812614_Chap11-1.gif /docserver/preview/fulltext/10.1128/9781555817848/9781555812614_Chap11-2.gif


This chapter discusses recent findings that may shed light on how pathogens circumvent the usually effective intestinal inflammatory defenses. Additionally, it discusses how nonpathogens and commensals may also have developed signals that inhibit or dampen host inflammatory pathways. Immune and inflammatory evasion by pathogens is an expected facet of parasitic life cycles, especially those that involve invasion into the corpus of the host. Prokaryotic life has an understandable affinity for intimate relationships with eukaryotic organisms. One, AvrBsT, is found in members of phytopathogenic bacteria ( spp.) that mediate the ‘’avirulence’’ function described. An AvrA homolog is present in most enteropathogenic spp. The blockade of proinflammatory pathways by chronic pathogens such as or may allow for long-term carriage that is characteristic of these infections. The chapter addresses how bacteria in the gut are capable of modifying host epithelia for their own purposes, and describes a biochemical pathway in human cells (NF-ΚB) by which both nonpathogens and pathogens may be able to attenuate host defense systems and noted specific effector proteins (Avr/Yop) that may mediate these effects.

Citation: Neish A. 2003. Microbial Interference with Host Inflammatory Responses, p 175-190. In Hecht G (ed), Microbial Pathogenesis and the Intestinal Epithelial Cell. ASM Press, Washington, DC. doi: 10.1128/9781555817848.ch11

Key Concept Ranking

Bacterial Proteins
African swine fever virus
Type III Secretion System
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

The Rel family and IB family. Each member is a separate gene. The 300-amino-acid Rel homology domain is shown as a black rectangle; the 33-amino-acid ankyrin repeats are shown as gray ovals.

Citation: Neish A. 2003. Microbial Interference with Host Inflammatory Responses, p 175-190. In Hecht G (ed), Microbial Pathogenesis and the Intestinal Epithelial Cell. ASM Press, Washington, DC. doi: 10.1128/9781555817848.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

The NF-B activation pathway. See text. In unstimulated cells, NF-B (a heterodimer of p50/p65) is sequestered in the cytoplasm by IB. Activation of proinflammatory signaling receptors, such as the TLR, sets in motion a series of enzymatic modifications of IB: phosphorylation, ubiquitination, and degradation. Loss of IB allows NF-B to translocate to the nucleus, bind to the promoters of numerous proinflammatory effector genes, and activate the epithelial proinflammatory program. Perturbation of any of these enzymatic steps could inhibit the entire pathway.

Citation: Neish A. 2003. Microbial Interference with Host Inflammatory Responses, p 175-190. In Hecht G (ed), Microbial Pathogenesis and the Intestinal Epithelial Cell. ASM Press, Washington, DC. doi: 10.1128/9781555817848.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Akari, H.,, S. Bour,, S. Kao,, A. Adachi,, and K. Strebel. 2001. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappa-B dependent expression of anti-apoptotic factors. J. Exp. Med. 194:12991312.
2. Alcamo, E.,, J. Mizgerd,, B. Horwitz,, R. Bronson,, A. Beg,, M. Scott,, C. Coerschuk,, R. Hynes,, and D. Baltimore. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NFkappa B in leukocyte recruitment. J. Immunol. 167:15921560.
3. Alvarez-Olmos, M.,, and R. Oberhelman. 2001. Probiotics and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis. 32:15671576.
4. Bauerle, P. 1998. Pro-inflammatory signalling: last pieces in the NF-κB puzzle? Curr. Biol. 8:1922.
5. Baumler, A.,, R. Tsolis,, T. Ficht,, and L. Adams. 1998. Evolution of host adaptation in Salmonella enterica. Infect. Immun. 66:45794587.
6. Beg, A.,, W. Sha,, R. Bronson,, S. Ghosh,, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappaB. Nature 376:167170.
7. Bour, S.,, C. Perrin,, H. Akari,, and K. Strebel. 2001. The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB. J. Biol. Chem. 276:1592015928.
8. Bry, L.,, P. Falk,, T. Midtvedt,, and J. Gordon. 1996. A model of host-microbial interactions in an open intestinal ecosystem. Science 273:13801383.
9. Butcher, B.,, L. Kim,, P. Johnson,, and E. Denkers. 2001. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J. Immunol. 167:21932201.
10. Chen, Z.,, J. Hagler,, V. Palombella,, F. Melandri,, D. Scherer,, D. Ballard,, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitinproteasome pathway. Genes Dev. 9:15861597.
11. Chen, Z.,, L. Parent,, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853862.
12. Ciesiolka, L.,, T. Hwin,, J. Gearlds,, G. Minsavage,, R. Saenz,, M. Bravo,, V. Handley,, S. Conover,, H. Zhang,, J. Caporgno,, N. Phengrasamy,, A. Toms,, R. Stall,, and M. Whalen. 1999. Regulation of expression of avirulence gene avrRxv and identification of a family of host interaction factors by sequence analysis of avrBst. Mol. Plant Microbe Interact. 12:3544.
13. Collins, T.,, M. Read,, A. Neish,, M. Whitley,, D. Thanos,, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:899909.
14. Cornelis, G.,, and F. Van Gijsegem. 2000. Assembly and function of type III secretion systems. Annu. Rev. Microbiol. 54:735774.
15. Cotran, R.,, V. Kumar,, and T. Collins. 1999. The Pathologic Basis of Disease, 6th ed. The W. B. Saunders Co., Philadelphia, Pa.
16. Cummings, C.,, and D. Relman. 2000. Using DNA microarrays to study host-microbe interactions. Emerg. Infect. Dis. 6:513525.
17. Dale, C.,, S. Young,, D. Haydon,, and S. Welburn. 2001. The insect symbiont Sodalis glossindus utilizes a type III secretion system for cell invasion. Proc. Natl. Acad. Sci. USA 98:18831888.
18. Dangl, J.,, and J. Jones. 2001. Plant pathogens and integrated defense responses to infection. Nature 411:826833.
19. Day, D.,, B. Mandall,, and B. Morrson. 1978. The rectal biopsy appearances of Salmonella colitis. Histopathology 2:117131.
20. Deng, L.,, C. Wang,, E. Spencer,, L. Yang,, A. Braun,, X. You,, C. Slaughter,, C. Pickart,, and Z. Chen. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351361.
21. DiDonato, J.,, M. Hayakawa,, D. Rothwarf,, E. Zandi,, and M. Karin. 1997. A cytokine-responsive IκB kinase that activated the transcription factor NF-κB. Nature 388:548554.
22. Donnenberg, M. 2000. Pathogenic strategies of enteric bacteria. Nature 406:768774.
23. Elewaut, D.,, J. DiDonato,, J. Kim,, F. Truong,, L. Eckmann,, and M. Kagnoff. 1999. NF-κB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 163:14571466.
24. Falk, P.,, L. Hooper,, T. Midtvedt,, and J. Gordon. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62:11571170.
25. Falkow, S.,, R. Isberg,, and D. Portnoy. 1992. The interaction of bacteria with mammalian cells. Annu. Rev. Cell Biol. 8:333363.
26. Foo, S.,, and G. Nolan. 1999. NF-κB to the rescue. Rel’s, apoptosis and cellular transformation. Trends Genet. 15:229235.
27. Freiberg, C.,, R. Fellay,, A. Bairoch,, W. Broughton,, A. Rosenthal,, and X. Perret. 1997. Molecular basis of symbiosis between Rhizobium and legumes. Nature 387:352353.
28. Galyov, E.,, M. Wood,, R. Rosqvist,, P. Mullan,, P. Watson,, S. Hedges,, and T. Wallis. 1997. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol. Microbiol. 25:903912.
29. Gewirtz, A.,, A. Rao,, P. Simon,, D. Merlin,, D. Carnes,, J. Madara,, and A. Neish. 2000. Salmonella typhimurium induces epithelial IL-8 expression via Ca+2-mediated activation of the NF-κB pathway. J. Clin. Invest. 105:7992.
30. Hacker, J.,, and J. Kaper. 2000. Pathogenicity islands and the evolution of microbes. Annu. Rev. Microbiol. 54:641679.
31. Hardt, W.-D.,, and J. Galan. 1997. A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc. Natl. Acad. Sci. USA 94:98879892.
32. Heissmeyer, V.,, D. Krappmann,, E. Hatada,, and C. Scheidereit. 2001. Shared pathways of IκB kinase-induced SCF (beta-TrCP)-mediated ubiquitination and degradation for the NF-κB precursor p105 and IκB alpha. Mol. Cell. Biol. 21:10241035.
33. Hobbie, S.,, L. Chen,, R. Davis,, and J. Galan. 1997. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 159:55505559.
34. Hoffman, J.,, F. Kafatos,, C. Janeway,, and R. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:13131318.
35. Hooper, L.,, L. Bry,, P. Falk,, and J. Gordon. 1998. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. BioEssays 20:336343.
36. Hooper, L.,, and J. Gordon. 2001. Commensal host-bacterial relationships in the gut. Science 292:11151118.
37. Hooper, L.,, M. Wong,, A. Thelin,, L. Hansson,, P. Falk,, and J. Gordon. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881884.
38. Jobin, C.,, and R. Sartor. 2000. The IκB/NF-κB system; a key determinant for mucosal inflammation and protection. Am. J. Physiol. 278:451462.
39. Karin, M. 1999. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J. Biol. Chem. 274:2733927342.
40. Karin, M.,, and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621663.
41. Klumpp, D.,, A. Weiser,, S. Sengupta,, S. Forrestal,, R. Batler,, and A. Schaeffer. 2001. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-κB. Infect. Immun. 69:66896695.
42. Kopp, E.,, and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:112.
43. Kunsch, C.,, and C. Rosen. 1993. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13:61376146.
44. Lee, C.,, M. Silva,, A. Siber,, A. Kelly,, E. Galyov,, and B. McCormick. 2000. A secreted Salmonella protein induces a proinflammatory response in epithelial cells, which promotes neutrophil migration. Proc. Natl. Acad. Sci. USA 97:1228312288.
45. Lemaitre, B.,, E. Nicolas,, L. Michaut,, J.-M. Reichart,, and J. Hoffman. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973983.
46. Looney, R.,, and R. Steigbigel. 1986. Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J. Lab. Clin. Med. 108:506516.
47. Maniatis, T. 1999. A ubiquitin ligase complex essential for the NF-κB, Wnt/wingless, and hedgehog signalling pathways. Genes Dev. 13:505510.
48. Masden, K.,, J. S. Doyle,, L. D. Jewell,, M. M. Tavernini,, and R. N. Fedorak. 1999. Lactobacillus sp. prevents olitis in interleukin-10 gene deficient mice. Gastroenterology 116:11071114.
49. May, M.,, and S. Ghosh. 1999. IκB kinases: kinsmen with different crafts. Science 284:271273.
50. Mozaffarian, N.,, A. Casadevall,, and J. Berman. 2000. Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans. J. Immunol. 165:15411547.
51. Neish, A.,, A. Gewirtz,, H. Zeng,, A. Young,, M. Hobert,, V. Karmali,, A. Rao,, and J. Madara. 2000. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289:15601563.
52. Oie, K.,, and D. Pickup. 2001. Cowpox virus and other members of the orthopoxvirus group interfere with the regulation of NF-κB activation. Virology 288:175187.
53. Orth, K.,, L. Palmer,, Z. Bao,, S. Stewart,, A. Rudolph,, J. Bliska,, and J. Dixon. 1999. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285:19201923.
54. Orth, K.,, Z. Xu,, M. Mudgett,, Z. Bao,, L. Palmer,, J. Bliska,, W. Mangel,, B. Staskawicz,, and J. Dixon. 2000. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290:15941597.
55. Palmer, L.,, A. Pancetti,, S. Greenberg,, and J. Bliska. 1999. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect. Immun. 67:708716.
56. Palombella, V.,, O. Rando,, A. Goldberg,, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773785.
57. Powell, P.,, L. Dixon,, and R. Parkhouse. 1996. An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J. Virol. 70:85278533.
58. Read, M.,, J. Brownell,, T. Gladysheva,, M. Hottelet,, L. Parent,, M. Coggins,, J. Pierce,, V. Podust,, R.-S. Luo,, V. Chau,, and J. Palombella. 2000. Nedd8 modification of Cul-1 activates SCF-β-TrCP-dependent ubiquitination of IκBa. Mol. Cell. Biol. 20:23262333.
59. Read, M.,, A. Neish,, F. Luscinskas,, V. Palombella,, T. Maniatis,, and T. Collins. 1995. The proteosome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2:493505.
60. Revilla, Y.,, M. Callejo,, J. Rodriguez,, E. Culebras,, M. Nogal,, M. Salas,, E. Vinulea,, and M. Fresno. 1998. Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein. J. Biol. Chem. 273:54055411.
61. Rosenberger, C.,, A. Pollard,, and B. Finlay. 2001. Gene array technology to determine host responses to Salmonella. Microbes Infect. 3:13531360.
62. Ruckdeschel, K.,, O. Mannel,, K. Richter,, C. Jacobi,, K. Trulzsch,, B. Rouot,, and J. Heesemann. 2001. Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-κB pathway and exploits lipopolysac charide signaling to trigger apoptosis in macrophages. J. Immunol. 166:18231831.
63. Sangari, F.,, M. Petrofsky,, and L. Bermudez. 1999. Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES. Infect. Immun. 67:50695075.
64. Schesser, K.,, A.-K. Spiik,, J.-M. Dukuzumuremyi,, M. Neurath,, S. Petterson,, and H. Wolf-Watz. 1998. The yopJ locus is required for Yersinia-mediated inhibition of the NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28:10671079.
65. Schwartz, A.,, and A. Ciechanover. 1999. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50:5774.
66. Senfteben, U.,, Y. Cao,, G. Xiao,, F. Greten,, G. Krahn,, G. Bonnizzi,, Y. Chen,, Y. Hu,, A. Fong,, S.-C. Sun,, and M. Karin. 2001. Activation by IKKα of a second evolutionary conserved, NF-κB signaling pathway. Science 293:14951499.
67. Sha, W.,, H. Liou,, E. Tuomanen,, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321330.
68. Silverman, N.,, and T. Maniatis. 2001. NF-κB signaling pathways in mammalian and insect immunity. Genes Dev. 15:23212342.
69. Spencer, E.,, J. Jiang,, and Z. Chen. 1999. Signal induced ubiquitination of IκBα by the F-box protein slimb/β-TrCP. Genes Dev. 13:284294.
70. Thanos, D.,, and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529532.
71. Varel, V. 1987. Activity of fiber degrading microorganisms in the pig large intestine. J. Anim. Sci. 65:488496.
72. Viprey, V.,, A. Del Greco,, W. Golinowski,, W. Broughton,, and X. Perret. 1998. Symbiotic implications of type III protein secretion machinery in Rhizobium. Mol. Microbiol. 28:13811389.
73. Wang, C.,, L. Deng,, M. Hong,, G. Akkaraju,, J.-I. Inoue,, and Z. Chen. 2001. Tak1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346351.
74. Wang, C.-Y.,, M. Mayo,, R. Korneluk,, D. Goeddel,, and A. Baldwin. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:16801683.
75. Wilkinson, F. 1997. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:12451256.
76. Wilson, K., 1995. The gastrointestinal microflora, p. 607615. In T. Yamada (ed.), Textbook of Gastroenterology, vol. 1. J. P. Lippincott, Philadelphia, Pa.
77. Wilson, M.,, R. Seymour,, and B. Henderson. 1998. Bacterial perturbation of cytokine networks. Infect. Immun. 66:24012409.
78. Winston, J.,, P. Strack,, P. Beer-Romero,, C. Chu,, S. Elledge,, and J. Harper. 1999. The SCF β-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13:270283.
79. Yeh, E.,, L. Gong,, and T. Kamitani. 2000. Ubiquitin-like proteins: new wines in new bottles. Gene 248:114.
80. Yuk, M. H.,, E. Harvill,, P. Cotter,, and J. F. Miller. 2000. Modulation of host immune responses, induction of apoptosis and inhibition of NF-κB activation by the Bordetella type III secretion system. Mol. Microbiol. 35:9911004.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error